Lord’s Mark Introduces India’s First AI-Driven Integrated Dialysis Ecosystem in Ahmedabad

The Lord’s Renal Renalyx Machine is a CE-certified, AI-powered hemodialysis system that functions alongside RenalOS, a clinical intelligence platform that enables real-time monitoring, predictive alerts, and decision support during dialysis sessions.

Lord’s Mark Industries has launched India’s first fully integrated AI-powered dialysis ecosystem at Shakti Super Speciality Hospital in Ahmedabad, built around the indigenously developed Renalyx machine, alongside AI-driven clinical and operational platforms.

Incorporated in 1998 and headquartered in Mumbai, Lord's Mark Industries operates in various businesses, such as healthcare, diagnostics, renewable energy, and printing and packaging. Aligning its growth strategy with the Make in India initiative, the company focuses on indigenous innovation for scalable and high-quality medical technologies.

The newly introduced ecosystem is structured across three layers. At its core is the Lord’s Renal Renalyx Machine, a CE-certified, AI-powered hemodialysis system designed and manufactured in India. It functions alongside RenalOS, a clinical intelligence platform that enables real-time monitoring, predictive alerts, and decision support during dialysis sessions.

Complementing this is Aureoon, a Dialysis-as-a-Service model that allows hospitals to deploy and operate dialysis centres without upfront capital expenditure.

Sachidanand Upadhyay, Managing Director, Lord’s Mark Industries, said, “This is one of Lord’s key AI-driven products within our larger technology portfolio, and we are committed to positioning India as a global leader in AI-based medical device development and manufacturing. The Lord’s Renal Renalyx Machine represents a fundamental shift in dialysis care. It brings together intelligent technology, indigenous manufacturing, and affordability to address some of the most critical challenges in renal care today. Our vision is to enable healthcare providers to deliver consistent, high-quality treatment at scale while building a globally competitive dialysis technology platform from India.”

The Renalyx system integrates automation with clinical workflows, supporting continuous monitoring of treatment parameters and early detection of complications such as haemodynamic instability.

Its cloud-enabled architecture allows remote supervision and longitudinal patient tracking, extending care beyond in-centre treatment to post-discharge monitoring. This approach is intended to move dialysis care from episodic intervention toward a more continuous and personalised model.

From an operational standpoint, the ecosystem allows hospitals to outsource infrastructure, staffing, and management while maintaining clinical quality, potentially lowering entry barriers for expanding dialysis services.

The company has stated plans to establish 50 such managed centres across India by March 2027, alongside scaling domestic machine deployment and exports to emerging markets.

Stay tuned for more such updates on Digital Health News